Skip to content
value.today

Biogen Inc. vs Divi's Laboratories Limited

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Biogen Inc. is the larger company by market value: $37.5 B against $32.0 B for Divi's Laboratories Limited, 1.2 times as much (market caps of Oct 23, 2026 for Biogen Inc. and Nov 20, 2026 for Divi's Laboratories Limited).
  • Biogen Inc. had more revenue: $9.9 B in the year to December 2025 against $1.1 B for Divi's Laboratories Limited in the year to March 2026.
  • Biogen Inc. earned more: net income of $1.3 B against $277 M for Divi's Laboratories Limited.
  • Divi's Laboratories Limited keeps more of each dollar of sales: a net margin of 24.5% against 13.1% for Biogen Inc.
  • Divi's Laboratories Limited employs more people: 13,884 against 7,500 at Biogen Inc. Each employee brings in about $1,318,747 of revenue at Biogen Inc. and $81,473 at Divi's Laboratories Limited.
  • On price to earnings, Divi's Laboratories Limited trades at 115.5× and Biogen Inc. at 108.0×: investors pay more for each dollar of Divi's Laboratories Limited's profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01192393584782020202120222023202420252026Biogen Inc. 51Divi's Laboratories Limited 472

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$4B$7B$11B$14B201720182019202020212022202320242025Biogen Inc. $10B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBiogen Inc.
BIIB · #692 in the world
Divi's Laboratories Limited
DIVISLAB.NS · #802 in the world
Profile
Country🇺🇸 USA🇮🇳 India
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19781990
Size
Market cap$37.5 B$32.0 B
Revenue$9.9 B$1.1 B
Net income$1.3 B▲ best$277 M
Employees7,50013,884
Valuation
P/E ratio108×115×
Price to sales3.6×28.3×
Price to book2.1×17.7×
Free cash flow yield5.5%—
Profitability
Gross margin75.7%—
Net margin13.1%—
Return on equity7.4%—
Growth
Revenue growth2.2%—
Revenue growth, 3 years a year-0.9%—
Earnings per share growth-21.4%—
Financial strength
Debt to equity0.3×—
Cash
Free cash flow margin20.7%—
Strength scores
Piotroski F-score4 of 9—
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Nov 2026

Questions and answers#

Which is bigger, Biogen Inc. or Divi's Laboratories Limited?

Biogen Inc. is the larger company by market value: $37.5 B against $32.0 B for Divi's Laboratories Limited, 1.2 times as much (market caps of Oct 23, 2026 for Biogen Inc. and Nov 20, 2026 for Divi's Laboratories Limited).

Which makes more money, Biogen Inc. or Divi's Laboratories Limited?

Biogen Inc. had more revenue: $9.9 B in the year to December 2025 against $1.1 B for Divi's Laboratories Limited in the year to March 2026. Biogen Inc. earned more: net income of $1.3 B against $277 M for Divi's Laboratories Limited.

Which is more profitable, Biogen Inc. or Divi's Laboratories Limited?

Divi's Laboratories Limited keeps more of each dollar of sales: a net margin of 24.5% against 13.1% for Biogen Inc.

Which has more employees, Biogen Inc. or Divi's Laboratories Limited?

Divi's Laboratories Limited employs more people: 13,884 against 7,500 at Biogen Inc. Each employee brings in about $1,318,747 of revenue at Biogen Inc. and $81,473 at Divi's Laboratories Limited.

Is Biogen Inc. cheaper than Divi's Laboratories Limited?

On price to earnings, Divi's Laboratories Limited trades at 115.5× and Biogen Inc. at 108.0×: investors pay more for each dollar of Divi's Laboratories Limited's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.